close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Physicians want to dispense drugs if pharmacists refuse

The American Medical Association (AMA) has approved a policy to permit physicians to dispense medication to patients, if a pharmacist refuses to fill a prescription because of conscientious objections.

At the AMA annual meeting in Chicago last week, delegates discussed how to deal with increasing numbers of pharmacists who are citing conscientious objection as a reason for not filling prescriptions. The response was overwhelming approval of a resolution for the AMA to pressure state legislatures to allow physicians to fill prescriptions for patients, when no pharmacist within a 30-mile radius agrees to do so.

According to Reuters, the new AMA policy also requested that the AMA lobby for legislation that "requires individual pharmacists or pharmacy chains to fill legally valid prescriptions or to provide immediate referral to an appropriate alternative dispensing pharmacy."

The impetus for the new AMA policy initially arose because some pharmacists began refusing to fill prescriptions for oral contraceptives and for the emergency contraceptive pill "Plan B". However, refusals have reportedly increased rapidly and now include psychiatric drugs (such as antidepressants) and pain medications. Moreover, some pharmacists refuse to return the prescription to the patient, preventing the patient from taking it to another pharmacy, or they lecture the patient.

AAFP President Mary Frank, MD, of Mill Valley, California, considers these actions inconsistent with professional protocol. "The pharmacist has the right to abide by his or her ethical principles or conscience, but not when that interferes with a decision the patient and doctor have made," said after the AMA vote. "The patient's needs have to take precedence."

Dr. Frank also pointed out that pharmacists might make faulty assumptions about a prescription, without knowing the specifics of a case. "Pharmacists...may refuse to fill a prescription for oral contraception, without knowing that the prescription is to treat polycystic ovary disease or menstrual cramps."

The American Pharmacists Association currently has no formal mechanism in place to deal with pharmacists who refuse to return prescriptions or to refer patients to a more compliant pharmacy. In cases where pharmacists pick up actual medication errors, such as incorrect dosage or unsafe drug combinations, the pharmacist are directed to contact the prescribing physician, discuss the problem and try to find a solution.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...